Abstract: A series of novel fusidic acid (FA) derivatives was synthesized by replacing the carboxylic acid group with various ester and amide groups and evaluated in vitro for their antiplasmodial activity against the chloroquine-sensitive NF54 and multidrugresistant K1 strains of the malarial parasite Plasmodium falciparum. Most of these derivatives showed a 4-49 and 5-17 fold increase in activity against NF54 and KI strains, respectively, as compared to FA and had a good selectivity index. These derivatives are stable over the incubation period and do not appear to be prodrugs of fusidic acid.
effective drugs such as chloroquine, sulfadoxine/pyrimethamine and artemisinin. 3, 4 In this context, the discovery and development of new molecules with novel mechanisms of action and no cross-resistance to current drugs is necessary.
Nature has always been a rich source of potential antimalarial agents. Two of the most effective antimalarial drugs quinine and artemisinin are natural products isolated from Cinchona officinalis and Artemisia annua, respectively, and many of the synthetic antimalarial drugs are analogues of these two natural products. [5] [6] [7] [8] Fusidic acid (FA) ( Figure 1 ) is a steroid-based, narrow spectrum bacteriostatic antibiotic belonging to a family of naturally occurring antibiotics, the fusidanes, which have a tetracyclic ring system with a unique chair-boat-chair proposed to be through inhibition of plasmodial EF-Gs, which harbour bacteria-like metabolic processes and are localised within the parasite's mitochondria and the relict apicoplast.
20,21
We have been exploring the antiplasmodial potential of FA and its derivatives.
Recently, we identified a number of FA derivatives with better (2-35 fold relative to FA)
antiplasmodial activity by replacing its carboxylic acid with various bioisosteres.present investigation, we report the synthesis and biological evaluation of novel aliphatic as well as aromatic ester and amide analoguesof FA.
The compounds synthesized for this study are presented in Table 1 with the corresponding synthetic routes outlined in Scheme 1. Target compounds were synthesized following a straightforward synthetic route involving a single step from commercially available fusidic acid 1 (Scheme 1). Aryl esters of fusidic acid 2a-o were obtained in moderate to good yield (38-89%, Table 1 corresponding alcohols in relatively poor yield (9-37%, Table 1 ). EDCI mediated coupling of 1 with corresponding amines on the other hand, afforded aromatic (2v) and aliphatic (2w-y)
amide derivatives in moderate to good yields (31-73%, Table 1 ). All the target compounds were purified using column chromatography and fully characterized by a range of analytical and spectroscopic techniques (see ESI †). The synthesized compounds were evaluated for their in vitro antiplasmodial activity against the chloroquine-sensitive NF54 strain, using the lactate dehydrogenase assay, and the multidrug-resistant K1 strain, using the modified [ 3 H]hypoxanthine incorporation assay. 23, 24 Chloroquine and artesunate were used as the reference drugs in all the experiments.
Compounds were also evaluated for cytotoxicity against a mammalian cell-line, Chinese
Hamster Ovarian (CHO) cells. The potencies of 2a-o indicated that aromatic ester derivatives were well tolerated.
Unsubstituted aromatic ester (2a, Table 1 Table 1 ), diminished their corresponding activities. All these aryl and alkyl ester derivatives (2a-u) were also tested for cytotoxicity and were found to be non-cytotoxic, as indicated by their high IC50
values against CHO cell lines as well as their high selectivity index values (Table 1) . Replacing an ester with an amide functionality seemed to have no effect on activity as aromatic amide derivative also retained the antiplasmodial activity (2v vs 2a, Table 1 ). However, long chain alkyl amide derivatives were found to be active, in striking contrast to their ester counterparts (2w and 2x vs 2s and 2t, respectively, Table 1 ). Amide derivatives also displayed favourable toxicity profiles as evident from their high SI values. In conclusion, a series of novel FA derivatives have been synthesized by replacing the carboxylic acid group with aliphatic as well as aromatic ester and amide groups, and evaluated in vitro for their antiplasmodial activity against NF54 and K1 strains of P. falciparum. Almost all of these analogues exhibited improved antiplasmodial activity relative to FA against both strains with good selectivity index values. The enhanced antiplasmodial activity substantiates the insignificance of a free carboxylic group for antiplasmodial activity. In addition, these derivatives were stable over the incubation period and were not converted to fusidic acid under the incubation conditions used and are therefore unlikely to act as prodrugs. Overall this work demonstrates the potential of FA as a promising novel antimalarial template.
